An update on clinical, pathological, diagnostic, and therapeutic perspectives of childhood leukodystrophies

References

• Vanderver A, Prust M, Tonduti D, et al. Case definition and classification of leukodystrophies and leukoencephalopathies. Mol Genet Metab. 2015;114(4):494–500.
   PubMed Web of Science ®Google Scholar
• Kevelam SH, Steenweg ME, Srivastava S, et al. Update on leukodystrophies: a historical perspective and adapted definition. Neuropediatrics. 2016;47(06):349–354.
   PubMedGoogle Scholar
• Van Der Knaap MS, Wolf NI, Heine VM. Leukodystrophies: five new things. Neurol Clin Pract. 2016;6(6):506–514.
   PubMedGoogle Scholar
• van der Knaap MS, Schiffmann R, Mochel F, et al. Diagnosis, prognosis, and treatment of leukodystrophies. Lancet Neurol. 2019;18(10):962–972.
   PubMed Web of Science ®Google Scholar
• Merzbacher L. Eine eigenartige familiär-hereditäre Erkrankungsform (Aplasia axialis extracorticalis congenita). Zeitschrift Für Die Gesamte Neurologie Und Psychiatrie. 1910;3(1):1–138.
   Google Scholar
• Pelizaeus F. Über eine eigenartige familiäre Entwicklungshemmung vornehmlich auf motorischem Gebiet. Archiv Für Psychiatrie Und Nervenkrankheiten. 1899;31:100–104.
   Google Scholar
• van der Knaap MS, Bugiani M. Leukodystrophies: a proposed classification system based on pathological changes and pathogenetic mechanisms. Acta Neuropathol. 2017;134(3):351–382.
   PubMed Web of Science ®Google Scholar
• Bielschowsky M, Henneberg R. Familiar diffuse sclerosis (Leucodystrophia cerebri progressiva hereditaria). Journal Fur Psychologie Und Neurologie. 1928;36:131–181.
   Google Scholar
• Morell P, Wiesmann U. A correlative synopsis of the leukodystrophies. Neuropediatrics. 1984;15(S 1):62–65.
   PubMedGoogle Scholar
• Parikh S, Bernard G, Leventer RJ, et al. A clinical approach to the diagnosis of patients with leukodystrophies and genetic leukoencephelopathies. Mol Genet Metab. 2015;114(4):501–515.
   PubMed Web of Science ®Google Scholar
• Kohlschütter A, Eichler F. Childhood leukodystrophies: a clinical perspective. Expert Rev Neurother. 2011;11(10):1485–1496.
   PubMed Web of Science ®Google Scholar
• Ashrafi MR, Tavasoli AR. Childhood leukodystrophies: a literature review of updates on new definitions, classification, diagnostic approach and management. Brain Dev. 2017;39(5):369–385.
   PubMed Web of Science ®Google Scholar
• Joss SK, Ghazawy S, Tomkins S, et al. Variable expression of neurological phenotype in autosomal recessive oculodentodigital dysplasia of two sibs and review of the literature. Eur J Pediatr. 2008;167(3):341–345.
   PubMed Web of Science ®Google Scholar
• Debeer P, Van Esch H, Huysmans C, et al. Novel GJA1 mutations in patients with oculo-dento-digital dysplasia (ODDD). Eur J Med Genet. 2005;48(4):377–387.
   PubMed Web of Science ®Google Scholar
• Mochel F, Schiffmann R, Steenweg ME, et al. Adult polyglucosan body disease: natural history and key magnetic resonance imaging findings. Ann Neurol. 2012;72(3):433–441.
   PubMed Web of Science ®Google Scholar
• Crow YJ. Aicardi-Goutières syndrome. InGeneReviews®[Internet]. Seattle: University of Washington; 2016.
   Google Scholar
• Budisteanu M, Arghir A, Chirieac SM, et al. 18q deletion syndrome–A case report. Maedica. 2010;5(2):135–138.
   PubMedGoogle Scholar
• Orcesi S, La Piana R, Fazzi E. Aicardi–goutieres syndrome. Br Med Bull. 2009;89(1):183–201.
   PubMed Web of Science ®Google Scholar
• Franco-Palacios MA, Martin MD, Wierenga KJ, et al. Case Report Adult polyglucosan body disease with reduced glycogen branching enzyme activity and heterozygous GBE1 mutation mimicking a low-grade glioma. Int J Clin Exp Pathol. 2016;9(3):4092–4100.
   Web of Science ®Google Scholar
• Keegan BM, Giannini C, Parisi JE, et al. Sporadic adult-onset leukoencephalopathy with neuroaxonal spheroids mimicking cerebral MS. Neurology. 2008;70:1128–1133.
   PubMed Web of Science ®Google Scholar
• Heim P, Claussen M, Hoffmann B, et al. Leukodystrophy incidence in Germany. Am J Med Genet A. 1997;71(4):475–478.
   PubMed Web of Science ®Google Scholar
• Bonkowsky JL, Nelson C, Kingston J, et al. The burden of inherited leukodystrophies in children. Neurology. 2010;75(8):718–725.
   PubMed Web of Science ®Google Scholar
• Vanderver A, Hussey H, Schmidt JL, et al., Relative incidence of inherited white matter disorders in childhood to acquired pediatric demyelinating disorders. Semin Pediatr Neurol. 2012;19(4):219–223.
   PubMed Web of Science ®Google Scholar
• Numata Y, Gotoh L, Iwaki A, et al. Epidemiological, clinical, and genetic landscapes of hypomyelinating leukodystrophies. J Neurol. 2014;261(4):752–758.
   PubMed Web of Science ®Google Scholar
• Ashrafi MR, Rezaei Z, Heidari M, et al. The first report of relative incidence of inherited white matter disorders in an Asian country based on an Iranian bioregistry system. J Child Neurol. 2018;33(4):255–259.
   PubMed Web of Science ®Google Scholar
• Bonkowsky JL, Wilkes J, Bardsley T, et al. Association of diagnosis of leukodystrophy with race and ethnicity among pediatric and adolescent patients. JAMA Network Open. 2018;1(7):e185031–e185031.
   PubMed Web of Science ®Google Scholar
• Holmes L Jr, Cornes MJ, Foldi B, et al. Clinical epidemiologic characterization of orthopaedic and neurological manifestations in children with leukodystrophies. J Pediatr Orthop. 2011;31(5):587–593.
   PubMed Web of Science ®Google Scholar
• Stellitano LA, Winstone AM, Van der Knaap MS, et al. Leukodystrophies and genetic leukoencephalopathies in childhood: a national epidemiological study. Dev Med Child Neurol. 2016;58(7):680–689.
   PubMed Web of Science ®Google Scholar
• Geren BB, Raskind J. Development of the fine structure of the myelin sheath in sciatic nerves of chick embryos. Proc Natl Acad Sci U S A. 1953;39(8):880.
   PubMed Web of Science ®Google Scholar
• Wood P, Bunge RP. The biology of the oligodendrocyte. In: “Oligodendroglia,” W.T. Norton, W.T. Plenum Press, New York. 1984. p. 1–46.
   Google Scholar
• Bjartmar C, Yin X, Trapp BD. Axonal pathology in myelin disorders. J Neurocytol. 1999;28(4–5):383–395.
   PubMedGoogle Scholar
• Block ML, Hong J-S. Microglia and inflammation-mediated neurodegeneration: multiple triggers with a common mechanism. Prog Neurobiol. 2005;76(2):77–98.
   PubMed Web of Science ®Google Scholar
• Bugiani M, Breur M. Leukodystrophies due to astroyctic dysfunction. Brain Pathol. 2018;28(3):369–371.
   PubMed Web of Science ®Google Scholar
• Min R, van der Knaap MS. Genetic defects disrupting glial ion and water homeostasis in the brain. Brain Pathol. 2018;28(3):372–387.
   PubMed Web of Science ®Google Scholar
• Neumann H, Kotter M, Franklin R. Debris clearance by microglia: an essential link between degeneration and regeneration. Brain. 2008;132(2):288–295.
   PubMedGoogle Scholar
• Pantoni L. Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges. Lancet Neurol. 2010;9(7):689–701.
   PubMed Web of Science ®Google Scholar
• Philips T, Rothstein JD. Oligodendroglia: metabolic supporters of neurons. J Clin Invest. 2017;127(9):3271–3280.
   PubMed Web of Science ®Google Scholar
• Román GC, Erkinjuntti T, Wallin A, et al. Subcortical ischaemic vascular dementia. Lancet Neurol. 2002;1(7):426–436.
   PubMed Web of Science ®Google Scholar
• Sasaki A, editor. Changing concept of microglia: microgliopathies. BRAIN PATHOLOGY. USA (NJ): WILEY 111 RIVER ST, HOBOKEN 07030-5774; 2019.
   Google Scholar
• Simons M, Nave K-A. Oligodendrocytes: myelination and axonal support. Cold Spring Harb Perspect Biol. 2016;8(1):a020479.
   Web of Science ®Google Scholar
• Zuchero JB, Barres BA. Intrinsic and extrinsic control of oligodendrocyte development. Curr Opin Neurobiol. 2013;23(6):914–920.
   PubMed Web of Science ®Google Scholar
• Torii T, Miyamoto Y, Yamauchi J, et al. P elizaeus–M erzbacher disease: cellular pathogenesis and pharmacologic therapy. Pediatr Int. 2014;56(5):659–666.
   PubMed Web of Science ®Google Scholar
• Charzewska A, Wierzba J, Iżycka‐Świeszewska E, et al. Hypomyelinating leukodystrophies—a molecular insight into the white matter pathology. Clin Genet. 2016;90(4):293–304.
   PubMed Web of Science ®Google Scholar
• Van Der Voorn JP, Pouwels PJ, Kamphorst W, et al. Histopathologic correlates of radial stripes on MR images in lysosomal storage disorders. Am J Neuroradiol. 2005;26(3):442–446.
   PubMed Web of Science ®Google Scholar
• Sakai N. Pathogenesis of leukodystrophy for Krabbe disease: molecular mechanism and clinical treatment. Brain Dev. 2009;31(7):485–487.
   PubMed Web of Science ®Google Scholar
• Guerra WF, Verity MA, Fluharty AL, et al. Multiple sulfatase deficiency: clinical, neuropathological, ultrastructural and biochemical studies. J Neuropathol Exp Neurol. 1990;49(4):406–423.
   PubMed Web of Science ®Google Scholar
• Singh I, Pujol A. Pathomechanisms underlying X‐adrenoleukodystrophy: a three‐hit hypothesis. Brain Pathol. 2010;20(4):838–844.
   PubMed Web of Science ®Google Scholar
• Szalardy L, Molnar M, Torok R, et al. Histopathological comparison of Kearns-Sayre syndrome and PGC-1alpha-deficient mice suggests a novel concept for vacuole formation in mitochondrial encephalopathy. Folia Neuropathol. 2016;54(1):9–22.
   PubMed Web of Science ®Google Scholar
• Huttenlocher PR. The neuropathology of phenylketonuria: human and animal studies. Eur J Pediatr. 2000;159(2):S102–S106.
   PubMedGoogle Scholar
• Van der Knaap MS, Valk J. Magnetic resonance of myelination and myelin disorders. Berlin: Springer Science & Business Media; 2005.
   Google Scholar
• Abrams CK, Freidin M. GJB1-associated X-linked Charcot–marie–tooth disease, a disorder affecting the central and peripheral nervous systems. Cell Tissue Res. 2015;360(3):659–673.
   PubMed Web of Science ®Google Scholar
• Gorospe JR, Maletkovic J. Alexander disease and megalencephalic leukoencephalopathy with subcortical cysts: leukodystrophies arising from astrocyte dysfunction. Ment Retard Dev Disabil Res Rev. 2006;12(2):113–122.
   PubMedGoogle Scholar
• Dietrich J, Lacagnina M, Gass D, et al. EIF2B5 mutations compromise GFAP+ astrocyte generation in vanishing white matter leukodystrophy. Nat Med. 2005;11(3):277.
   PubMed Web of Science ®Google Scholar
• Mahammad S, Murthy SP, Didonna A, et al. Giant axonal neuropathy–associated gigaxonin mutations impair intermediate filament protein degradation. J Clin Invest. 2013;123(5):1964–1975.
   PubMed Web of Science ®Google Scholar
• De Bock M, Kerrebrouck M, Wang N, et al. Neurological manifestations of oculodentodigital dysplasia: a Cx43 channelopathy of the central nervous system?. Front Pharmacol. 2013;4:120.
   PubMed Web of Science ®Google Scholar
• Jeworutzki E, López-Hernández T, Capdevila-Nortes X, et al. GlialCAM, a protein defective in a leukodystrophy, serves as a ClC-2 Cl− channel auxiliary subunit. Neuron. 2012;73(5):951–961.
   PubMed Web of Science ®Google Scholar
• Cuadrado E, Jansen MH, Anink J, et al. Chronic exposure of astrocytes to interferon-α reveals molecular changes related to Aicardi–goutières syndrome. Brain. 2013;136(1):245–258.
   PubMedGoogle Scholar
• Gazzerro E, Baldassari S, Giacomini C, et al. Hyccin, the molecule mutated in the leukodystrophy hypomyelination and congenital cataract (HCC), is a neuronal protein. PLoS One. 2012;7(3):e32180.
   PubMed Web of Science ®Google Scholar
• Hamilton EM, Polder E, Vanderver A, et al. Hypomyelination with atrophy of the basal ganglia and cerebellum: further delineation of the phenotype and genotype–phenotype correlation. Brain. 2014;137(7):1921–1930.
   PubMedGoogle Scholar
• van der Voorn JP, Kamphorst W, van der Knaap MS, et al. The leukoencephalopathy of infantile GM1 gangliosidosis: oligodendrocytic loss and axonal dysfunction. Acta Neuropathol. 2004;107(6):539–545.
   PubMed Web of Science ®Google Scholar
• Haberland C, Brunngraber E, Witting L, et al. The white matter in gangliosidosis. Acta Neuropathol. 1973;24(1):43–55.
   PubMed Web of Science ®Google Scholar
• Wolf NI, van der Knaap MS. AGC1 deficiency and cerebral hypomyelination. N Engl J Med. 2009;361(20):1997–1998.
   PubMedGoogle Scholar
• Magen D, Georgopoulos C, Bross P, et al. Mitochondrial hsp60 chaperonopathy causes an autosomal-recessive neurodegenerative disorder linked to brain hypomyelination and leukodystrophy. Am J Hum Genet. 2008;83(1):30–42.
   PubMed Web of Science ®Google Scholar
• Bergner CG, Van Der Meer F, Winkler A, et al. Microglia damage precedes major myelin breakdown in X‐linked adrenoleukodystrophy and metachromatic leukodystrophy. Glia. 2019;67(6):1196–1209.
   PubMed Web of Science ®Google Scholar
• Ohgidani M, Kato TA, Setoyama D, et al. Direct induction of ramified microglia-like cells from human monocytes: dynamic microglial dysfunction in Nasu-Hakola disease. Sci Rep. 2014;4:4957.
   PubMed Web of Science ®Google Scholar
• Rademakers R, Baker M, Nicholson AM, et al. Mutations in the colony stimulating factor 1 receptor (CSF1R) gene cause hereditary diffuse leukoencephalopathy with spheroids. Nat Genet. 2012;44(2):200.
   Web of Science ®Google Scholar
• Mandybur TI. Cerebral amyloid angiopathy: the vascular pathology and complications. J Neuropathol Exp Neurol. 1986;45(1):79–90.
   PubMed Web of Science ®Google Scholar
• Tikka S, Baumann M, Siitonen M, et al. cADAsIL and cARAsIL. Brain Pathol. 2014;24(5):525–544.
   PubMed Web of Science ®Google Scholar
• Wargon I, Lacour M, Adams D, et al. A small deep infarct revealing leukoencephalopathy, calcifications and cysts in an adult patient. J Neurol Neurosurg. 2008;79(2):224–225.
   Web of Science ®Google Scholar
• Boulloche J, Aicardi J. Pelizaeus-Merzbacher disease: clinical and nosological study. J Child Neurol. 1986;1(3):233–239.
   PubMed Web of Science ®Google Scholar
• Haenggeli CA, Engel E, Pizzolato GP. Connatal Pelizaeus‐Merzbacher Disease. Dev Med Child Neurol. 1989;31(6):803–807.
   PubMed Web of Science ®Google Scholar
• Kono T, Moriyama N, Tanaka R, et al. Tigroid pattern of the white matter: a previously unrecognized MR finding in lissencephaly with cerebellar hypoplasia. Pediatr Radiol. 2008;38(10):1105.
   PubMed Web of Science ®Google Scholar
• Krägeloh-Mann I, Groeschel S, Kehrer C, et al. Juvenile metachromatic leukodystrophy 10 years post transplant compared with a non-transplanted cohort. Bone Marrow Transplant. 2013;48(3):369.
   PubMed Web of Science ®Google Scholar
• Laukka JJ, Kamholz J, Bessert D, et al. Novel pathologic findings in patients with Pelizaeus-Merzbacher disease. Neurosci Lett. 2016;627:222–232.
   PubMed Web of Science ®Google Scholar
• Almarzooqi S, Quadri A, Albawardi A. Gallbladder polyps in metachromatic leukodystrophy. Fetal Pediatr Pathol. 2018;37(2):102–108.
   PubMed Web of Science ®Google Scholar
• Dooves S, Bugiani M, Postma NL, et al. Astrocytes are central in the pathomechanisms of vanishing white matter. J Clin Invest. 2016;126(4):1512–1524.
   PubMed Web of Science ®Google Scholar
• Suzuki K, Vanier MT. Sphingolipidoses. In: Golden JA, Arding BN, editors. Pathology & genetics developmental neuropathology. Basel: ISN Neuropath; 2004. p. 235–236.
   Google Scholar
• Harbord M, Harden A, Harding B, et al. Megalencephaly with dysmyelination, spasticity, ataxia, seizures and distinctive neurophysiological findings in two siblings. Neuropediatrics. 1990;21(03):164–168.
   PubMedGoogle Scholar
• Sosunov AA, McKhann GM, Goldman JE. The origin of Rosenthal fibers and their contributions to astrocyte pathology in Alexander disease. Acta Neuropathol Commun. 2017;5(1):27.
   PubMedGoogle Scholar
• Van der Knaap M, Barth P, Vrensen G, et al. Histopathology of an infantile-onset spongiform leukoencephalopathy with a discrepantly mild clinical course. Acta Neuropathol. 1996;92(2):206–212.
   PubMed Web of Science ®Google Scholar
• Van der Knaap M, Linnankivi T, Paetau A, et al. Hypomyelination with atrophy of the basal ganglia and cerebellum: follow-up and pathology. Neurology. 2007;69(2):166–171.
   PubMed Web of Science ®Google Scholar
• Van der Knaap M, Naidu S, Kleinschmidt-Demasters B, et al. Autosomal dominant diffuse leukoencephalopathy with neuroaxonal spheroids. Neurology. 2000;54(2):463.
   PubMed Web of Science ®Google Scholar
• van der Knaap MS, Pronk JC, Scheper GC. Vanishing white matter disease. Lancet Neurol. 2006;5(5):413–423.
   PubMed Web of Science ®Google Scholar
• Van Haren K, Van Der Voorn JP, Peterson DR, et al. The life and death of oligodendrocytes in vanishing white matter disease. J Neuropathol Exp Neurol. 2004;63(6):618–630.
   PubMed Web of Science ®Google Scholar
• Osterman B, La Piana R, Bernard G. Advances in the diagnosis of leukodystrophies. Future Neurol. 2012;7(5):595–612.
   Google Scholar
• van der Knaap MS, Abbink TE, Min R Megalencephalic leukoencephalopathy with subcortical cysts. GeneReviews®[Internet]: University of Washington, Seattle; 2018.
   Google Scholar
• Steenweg ME, Ghezzi D, Haack T, et al. Leukoencephalopathy with thalamus and brainstem involvement and high lactate ‘LTBL’caused by EARS2 mutations. Brain. 2012;135(5):1387–1394.
   PubMedGoogle Scholar
• Adang LA, Sherbini O, Ball L, et al. Revised consensus statement on the preventive and symptomatic care of patients with leukodystrophies. Mol Genet Metab. 2017;122(1–2):18–32.
   PubMed Web of Science ®Google Scholar
• Waldman AT. Leukodystrophies. Continuum. 2018;24(1):130–149.
   PubMedGoogle Scholar
• Erro R, Hersheson J, Ganos C, et al. H‐ABC syndrome and DYT4: variable expressivity or pleiotropy of TUBB4 mutations? Mov Disord. 2015;30(6):828–833.
   PubMed Web of Science ®Google Scholar
• Prust M, Wang J, Morizono H, et al. GFAP mutations, age at onset, and clinical subtypes in Alexander disease. Neurology. 2011;77(13):1287–1294.
   PubMed Web of Science ®Google Scholar
• Schuster J, Sundblom J, Thuresson A-C, et al. Genomic duplications mediate overexpression of lamin B1 in adult-onset autosomal dominant leukodystrophy (ADLD) with autonomic symptoms. Neurogenetics. 2011;12(1):65–72.
   PubMed Web of Science ®Google Scholar
• Freeman SH, Hyman BT, Sims KB, et al. Adult onset leukodystrophy with neuroaxonal spheroids: clinical, neuroimaging and neuropathologic observations. Brain Pathol. 2009;19(1):39–47.
   PubMed Web of Science ®Google Scholar
• Köhler W, Curiel J, Vanderver A. Adulthood leukodystrophies. Nat Rev Neurol. 2018;14(2):94.
   PubMed Web of Science ®Google Scholar
• Kemp S, Pujol A, Waterham HR, et al. ABCD1 mutations and the X‐linked adrenoleukodystrophy mutation database: role in diagnosis and clinical correlations. Hum Mutat. 2001;18(6):499–515.
   PubMed Web of Science ®Google Scholar
• Crow YJ, Chase DS, Lowenstein Schmidt J, et al. Characterization of human disease phenotypes associated with mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, ADAR, and IFIH1. Am J Med Genet Part A. 2015;167(2):296–312.
   Web of Science ®Google Scholar
• Wenger DA. Krabbe disease. GeneReviews®[Internet]. Seattle: University of Washington; 2011.
   Google Scholar
• Rezaei N, Nikbakht S, Ashrafi M-R, et al. Seizure as the early and main manifestation of infantile vanishing white matter disease: A case report. Iran J Pediatr. 2018;28:2.
   Web of Science ®Google Scholar
• Haberlandt E, Scholl-Bürgi S, Neuberger J, et al. Peripheral neuropathy as the sole initial finding in three children with infantile metachromatic leukodystrophy. Eur J Paediatr Neurol. 2009;13(3):257–260.
   PubMed Web of Science ®Google Scholar
• Korn-Lubetzki I, Dor-Wollman T, Soffer D, et al. Early peripheral nervous system manifestations of infantile Krabbe disease. Pediatr Neurol. 2003;28(2):115–118.
   PubMed Web of Science ®Google Scholar
• Kameli R, Ashrafi MR, Ehya F, et al. Leukoencephalopathy in RIN2 syndrome: novel mutation and expansion of clinical spectrum. Eur J Med Genet. 2019 Feb 13;103629.
   PubMed Web of Science ®Google Scholar
• Steenweg ME, Vanderver A, Blaser S, et al. Magnetic resonance imaging pattern recognition in hypomyelinating disorders. Brain. 2010;133(10):2971–2982.
   PubMed Web of Science ®Google Scholar
• Datar R, Prasad AN, Tay KY, et al. Magnetic resonance imaging in the diagnosis of white matter signal abnormalities. Neuroradiol J. 2018;31(4):362–371.
   PubMed Web of Science ®Google Scholar
• Desai NK, Mullins ME. An imaging approach to diffuse white matter changes. Radiol Clin North Am. 2014;52(2):263–278.
   PubMed Web of Science ®Google Scholar
• van der Knaap MS. Magnetic resonance in childhood white-matter disorders The 2001 Ronnie Mac Keith Lecture. Dev Med Child Neurol. 2001;43(10):705–712.
   PubMed Web of Science ®Google Scholar
• Schiffmann R, van der Knaap MS. Invited article: an MRI-based approach to the diagnosis of white matter disorders. Neurology. 2009;72(8):750–759.
   PubMed Web of Science ®Google Scholar
• Barreau P, Prust MJ, Crane J, et al. Focal central white matter lesions in Alexander disease. J Child Neurol. 2011;26(11):1422–1424.
   PubMed Web of Science ®Google Scholar
• Pouwels PJW, Vanderver A, Bernard G, et al. Hypomyelinating leukodystrophies: translational research progress and prospects. Ann Neurol. 2014;76(1):5–19.
   PubMed Web of Science ®Google Scholar
• Blattner R, Von Moers A, Leegwater P, et al. Clinical and genetic heterogeneity in megalencephalic leukoencephalopathy with subcortical cysts (MLC). Neuropediatrics. 2003;34(04):215–218.
   PubMedGoogle Scholar
• Vanderver A, Prust M, Kadom N, et al. Early-Onset Aicardi-Goutières Syndrome. J Child Neurol. 2015;30(10):1343–1348.
   PubMed Web of Science ®Google Scholar
• Kameli R, Amanat M, Rezaei Z, et al. RNASET2-deficient leukoencephalopathy mimicking congenital CMV infection and Aicardi-Goutieres syndrome: a case report with a novel pathogenic variant. Orphanet J Rare Dis. 2019;14(1):184.
   PubMedGoogle Scholar
• Sureka J, Jakkani RK. Clinico-radiological spectrum of bilateral temporal lobe hyperintensity: a retrospective review. Br J Radiol. 2012;85(1017):e782–e792.
   PubMed Web of Science ®Google Scholar
• Ulrick N, Goldstein A, Simons C, et al. RMND1-related leukoencephalopathy with temporal lobe cysts and hearing loss—another mendelian mimicker of congenital cytomegalovirus infection. Pediatr Neurol. 2017;66:59–62.
   PubMed Web of Science ®Google Scholar
• Van der Knaap M, Barth P, Gabreëls F, et al. A new leukoencephalopathy with vanishing white matter. Neurology. 1997;48(4):845–854.
   PubMed Web of Science ®Google Scholar
• Invernizzi F, Ardissone A, Lamantea E, et al. Cavitating leukoencephalopathy with multiple mitochondrial dysfunction syndrome and NFU1 mutations. Front Genet. 2014;5:412.
   PubMed Web of Science ®Google Scholar
• van der Knaap MS, Salomons GS, Li R, et al. Unusual variants of Alexander’s disease. Ann Neurol. 2005;57(3):327–338.
   PubMed Web of Science ®Google Scholar
• Hennel SJ, Ekert PG, Volpe JJ, et al. Insights into the pathogenesis of cerebral lesions in incontinentia pigmenti. Pediatr Neurol. 2003;29(2):148–150.
   PubMed Web of Science ®Google Scholar
• Fawer C, Calame A, Perentes E, et al. Periventricular leukomalacia: a correlation study between real-time ultrasound and autopsy findings. Neuroradiology. 1985;27(4):292–300.
   PubMed Web of Science ®Google Scholar
• Steiner J, Adamsbaum C, Desguerres I, et al. Hypomelanosis of Ito and brain abnormalities: MRI findings and literature review. Pediatr Radiol. 1996;26(11):763–768.
   PubMed Web of Science ®Google Scholar
• Allmendinger AM, Desai NS, Burke AT, et al. Neuroimaging and renal ultrasound manifestations of Oculocerebrorenal syndrome of Lowe. J Radiol Case Rep. 2014;8(10):1.
   PubMedGoogle Scholar
• Reichert R, Campos LG, Vairo F, et al. Neuroimaging findings in patients with mucopolysaccharidosis: what you really need to know. Radiographics. 2016;36(5):1448–1462.
   PubMed Web of Science ®Google Scholar
• Van Der Knaap M, Kriek M, Overweg-Plandsoen W, et al. Cerebral white matter abnormalities in 6p25 deletion syndrome. Am J Neuroradiol. 2006;27(3):586–588.
   PubMed Web of Science ®Google Scholar
• Sener U, Zorlu Y, Men S, et al. Leukoencephalopathy, cerebral calcifications, and cysts. Am J Neuroradiol. 2006;27(1):200–203.
   PubMed Web of Science ®Google Scholar
• Woody RC, Brewster MA, Glasier C. Progressive intracranial calcification in dihydropteridine reductase deficiency prior to folinic acid therapy. Neurology. 1989;39(5):673.
   PubMed Web of Science ®Google Scholar
• Mahajnah M, Abu-Rashid M, Lerman-Sagie T, et al. Alexander disease in Israel: megalencephaly and Leukoencephalopathy and its differential diagnosis. J Paediatr Neurol. 2015;13(03):121–125.
   Google Scholar
• Alexander AL, Lee JE, Lazar M, et al. Diffusion tensor imaging of the brain. Neurotherapeutics. 2007;4(3):316–329.
   PubMed Web of Science ®Google Scholar
• Guo AC, Petrella JR, Kurtzberg J, et al. Evaluation of white matter anisotropy in Krabbe disease with diffusion tensor MR imaging: initial experience. Radiology. 2001;218(3):809–815.
   PubMed Web of Science ®Google Scholar
• Koob M, Rousseau F, Laugel V, et al. Cockayne syndrome: a diffusion tensor imaging and volumetric study. Br J Radiol. 2016;89(1067):20151033.
   PubMed Web of Science ®Google Scholar
• van Rappard DF, Königs M, Steenweg ME, et al. Diffusion tensor imaging in metachromatic leukodystrophy. J Neurol. 2018;265(3):659–668.
   PubMed Web of Science ®Google Scholar
• Choi M, Scholl UI, Ji W, et al. Genetic diagnosis by whole exome capture and massively parallel DNA sequencing. Proc Nat Acad Sci. 2009;106(45):19096–19101.
   PubMed Web of Science ®Google Scholar
• Topper S, Ober C, Das S. Exome sequencing and the genetics of intellectual disability. Clin Genet. 2011;80(2):117–126.
   PubMed Web of Science ®Google Scholar
• Rezaei Z, Hosseinpour S, Ashrafi MR, et al. Hypomyelinating leukodystrophy with spinal cord involvement caused by a novel variant in RARS: report of two unrelated patients. Neuropediatrics. 2019;50(02):130–134.
   PubMedGoogle Scholar
• Fogel BL, Lee H, Deignan JL, et al. Exome sequencing in the clinical diagnosis of sporadic or familial cerebellar ataxia. JAMA Neurol. 2014;71(10):1237–1246.
   PubMed Web of Science ®Google Scholar
• Petersen B-S, Fredrich B, Hoeppner MP, et al. Opportunities and challenges of whole-genome and-exome sequencing. BMC Genet. 2017;18(1):14.
   PubMed Web of Science ®Google Scholar
• Baldridge D, Heeley J, Vineyard M, et al. The Exome Clinic and the role of medical genetics expertise in the interpretation of exome sequencing results. Genet Med. 2017;19(9):1040.
   PubMed Web of Science ®Google Scholar
• Soden SE, Saunders CJ, Willig LK, et al. Effectiveness of exome and genome sequencing guided by acuity of illness for diagnosis of neurodevelopmental disorders. Sci Transl Med. 2014;6(265):265ra168–265ra168.
   PubMed Web of Science ®Google Scholar
• Henneke M, Gegner S, Hahn A, et al. Clinical neurophysiology in GJA12-related hypomyelination vs Pelizaeus-Merzbacher disease. Neurology. 2010;74(22):1785–1789.
   PubMed Web of Science ®Google Scholar
• Wang D, Gao G. State-of-the-art human gene therapy: part Ii. gene therapy strategies and applications. Discov Med. 2014;18(98):151.
   PubMed Web of Science ®Google Scholar
• Ginn SL, Alexander IE, Edelstein ML, et al. Gene therapy clinical trials worldwide to 2012–an update. J Gene Med. 2013;15(2):65–77.
   PubMed Web of Science ®Google Scholar
• Eichler F, Duncan C, Musolino PL, et al. Hematopoietic stem-cell gene therapy for cerebral adrenoleukodystrophy. N Engl J Med. 2017;377(17):1630–1638.
   PubMed Web of Science ®Google Scholar
• Sessa M, Lorioli L, Fumagalli F, et al. Lentiviral haemopoietic stem-cell gene therapy in early-onset metachromatic leukodystrophy: an ad-hoc analysis of a non-randomised, open-label, phase 1/2 trial. Lancet. 2016;388(10043):476–487.
   PubMed Web of Science ®Google Scholar
• Biffi A, Montini E, Lorioli L, et al. Lentiviral hematopoietic stem cell gene therapy benefits metachromatic leukodystrophy. Science. 2013;341(6148):1233158.
   PubMed Web of Science ®Google Scholar
• Leone P, Shera D, McPhee SW, et al. Long-term follow-up after gene therapy for canavan disease. Sci Transl Med. 2012;4(165):165ra163–165ra163.
   PubMed Web of Science ®Google Scholar
• Godfrey C, Desviat LR, Smedsrød B, et al. Delivery is key: lessons learnt from developing splice‐switching antisense therapies. EMBO Mol Med. 2017;9(5):545–557.
   PubMed Web of Science ®Google Scholar
• Hagemann TL, Powers B, Mazur C, et al. Antisense suppression of glial fibrillary acidic protein as a treatment for Alexander disease. Ann Neurol. 2018;83(1):27–39.
   PubMed Web of Science ®Google Scholar
• Long C, Amoasii L, Mireault AA, et al. Postnatal genome editing partially restores dystrophin expression in a mouse model of muscular dystrophy. Science. 2016;351(6271):400–403.
   PubMed Web of Science ®Google Scholar
• Anzalone AV, Randolph PB, Davis JR, et al. Search-and-replace genome editing without double-strand breaks or donor DNA. Nature. 2019 Oct 21. doi:10.1038/s41586-019-1711-4
   PubMed Web of Science ®Google Scholar
• Köhler W, Kühl J-S. Hematopoietic stem cell transplantation for adult cerebral X-linked adrenoleukodystrophy (P5. 174). Neurology. 2014;82(Suppl_10) P5.174.
   Google Scholar
• van Geel BM, Verrips A, Boelens -J-J, et al. Hematopoietic cell transplantation does not prevent myelopathy in X-linked adrenoleukodystrophy: a retrospective study. J Inherit Metab Dis. 2015;38(2):359–361.
   PubMed Web of Science ®Google Scholar
• Boucher AA, Miller W, Shanley R, et al. Long-term outcomes after allogeneic hematopoietic stem cell transplantation for metachromatic leukodystrophy: the largest single-institution cohort report. Orphanet J Rare Dis. 2015;10(1):94.
   PubMedGoogle Scholar
• Graf WD. Stem cell transplantation in Krabbe disease. Neurology. 2017;89 (13):1318–1319.
   Google Scholar
• Uchida N, Chen K, Dohse M, et al. Human neural stem cells induce functional myelination in mice with severe dysmyelination. Sci Transl Med. 2012;4(155):155ra136–155ra136.
   PubMed Web of Science ®Google Scholar
• Casarosa S, Bozzi Y, Conti L. Neural stem cells: ready for therapeutic applications? Mol Cell Ther. 2014;2(1):31.
   PubMedGoogle Scholar
• Dooves S, Leferink PS, Krabbenborg S, et al. Cell replacement therapy improves pathological hallmarks in a mouse model of leukodystrophy vanishing white matter. Stem Cell Reports. 2019;12(3):441–450.
   PubMed Web of Science ®Google Scholar
• Doerr J, Böckenhoff A, Ewald B, et al. Arylsulfatase A overexpressing human iPSC-derived neural cells reduce CNS sulfatide storage in a mouse model of metachromatic leukodystrophy. Mol Ther. 2015;23(9):1519–1531.
   PubMed Web of Science ®Google Scholar
• Dooves S, van der Knaap MS, Heine VM. Stem cell therapy for white matter disorders: don’t forget the microenvironment! J Inherit Metab Dis. 2016;39(4):513–518.
   PubMed Web of Science ®Google Scholar
• Van Haren K, Bonkowsky JL, Bernard G, et al. Consensus statement on preventive and symptomatic care of leukodystrophy patients. Mol Genet Metab. 2015;114(4):516–526.
   PubMed Web of Science ®Google Scholar
• Helman G, Van Haren K, Bonkowsky JL, et al. Disease specific therapies in leukodystrophies and leukoencephalopathies. Mol Genet Metab. 2015;114(4):527–536.
   PubMed Web of Science ®Google Scholar
• Wang P, Xu L, Sun A. Energy remodeling, mitochondrial disorder and heart failure. Curr Pharm Des. 2016;22(31):4823–4829.
   PubMed Web of Science ®Google Scholar
• Jaber L, Shohat M, Bu X, et al. Sensorineural deafness inherited as a tissue specific mitochondrial disorder. J Med Genet. 1992;29(2):86–90.
   PubMed Web of Science ®Google Scholar
• Patrinos G, Danielson P, Ansorge W. Molecular diagnostics: past, present, and future. In: Molecular Diagnostics (Third Edition). Patrinos GP (Ed.). Academic Press. 2017. p. 1–11.
   Google Scholar
• Collins FS, Gottlieb S. The next phase of human gene-therapy oversight. N Engl J Med. 2018;379(15):1393–1395.
   PubMed Web of Science ®Google Scholar
• Hamilton EM, van der Lei HD, Vermeulen G, et al. Natural history of vanishing white matter. Ann Neurol. 2018;84(2):274–288.
   PubMed Web of Science ®Google Scholar
• Langan TJ, Barczykowski A, Jalal K, et al. Survey of quality of life, phenotypic expression, and response to treatment in Krabbe leukodystrophy. JIMD Rep. 2019;47(1):47–54.
   PubMedGoogle Scholar
• Duffner PK, Caggana M, Orsini JJ, et al. Newborn screening for Krabbe disease: the New York State model. Pediatr Neurol. 2009;40(4):245–252.
   PubMed Web of Science ®Google Scholar
• Armangue T, Orsini JJ, Takanohashi A, et al. Neonatal detection of Aicardi Goutières Syndrome by increased C26: 0 lysophosphatidylcholine and interferon signature on newborn screening blood spots. Mol Genet Metab. 2017;122(3):134–139.
   PubMed Web of Science ®Google Scholar
• Mirchi A, Pelletier F, Tran LT, et al. Health-related quality of life for patients with genetically determined leukoencephalopathy. Pediatr Neurol. 2018;84:21–26.
   PubMed Web of Science ®Google Scholar